Hospital-level variation in the quality of urologic cancer surgery

Cancer

Volumn 118, Issue 4, 2012, Pages 987-996

  Gore, John L ^a   Wright, Jonathan L ^a,b   Daratha, Kenn B ^c   Roberts, Kenneth P ^d   Lin, Daniel W ^a,b   Wessells, Hunter ^a   Porter, Michael ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

bladder carcinoma; kidney carcinoma; prostate carcinoma; quality of care

Indexed keywords

ADULT; AGED; ARTICLE; CYSTECTOMY; FEMALE; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PATIENT IDENTIFICATION; PATIENT SAFETY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; SURGICAL MORTALITY; THROMBOEMBOLISM; AGE; BLADDER CANCER; CANCER SURGERY; CAUSE OF DEATH; CLINICAL PRACTICE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; KIDNEY CARCINOMA; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PROSTATE CANCER; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CYSTECTOMY; FEMALE; HUMANS; KIDNEY NEOPLASMS; LENGTH OF STAY; MALE; MIDDLE AGED; NEPHRECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SURGERY DEPARTMENT, HOSPITAL; URINARY BLADDER NEOPLASMS; WASHINGTON; YOUNG ADULT;

EID: 84856779610     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26373     Document Type: Article

References (32)

1. Dodgion CM, Greenberg CC,. Using population-based registries to study variations in health care. J Oncol Pract. 2009; 5: 319-320.
2. The Center for Evaluative Clinical Sciences. The Dartmouth Atlas of Health Care, 1999. Chicago, IL: American Hospital Publishing; 1999.
3. Krupski TL, Kwan L, Afifi AA, Litwin MS,. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol. 2005; 23: 7881-7888.
4. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE,. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA. 1993; 269: 2633-2636.
5. Gore JL, Litwin MS, Lai J, et al. Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst. 2010; 102: 802-811.
6. Miller DC, Saigal CS, Banerjee M, Hanley J, Litwin MS,. Diffusion of surgical innovation among patients with kidney cancer. Cancer. 2008; 112: 1708-1717.
7. Miller DC, Saigal CS, Warren JL, et al. External validation of a claims-based algorithm for classifying kidney-cancer surgeries [serial online]. BMC Health Serv Res. 2009; 9: 92.
8. Elixhauser A, Steiner C, Harris DR, Coffey RM,. Comorbidity measures for use with administrative data. Med Care. 1998; 36: 8-27.
9. Begg CB, Cramer LD, Hoskins WJ, Brennan MF,. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280: 1747-1751.
10. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002; 346: 1138-1144.
11. Hollenbeck BK, Wei Y, Birkmeyer JD,. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology. 2007; 69: 871-875.
12. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS,. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol. 2003; 21: 401-405.
13. Romano PS, Geppert JJ, Davies S, Miller MR, Elixhauser A, McDonald KM,. A national profile of patient safety in US hospitals. Health Aff (Millwood). 2003; 22: 154-166.
14. Shahian DM, Torchiana DF, Shemin RJ, Rawn JD, Normand SL,. Massachusetts cardiac surgery report card: implications of statistical methodology. Ann Thorac Surg. 2005; 80: 2106-2113.
15. Daniels MJ, Gatsonis C,. Hierarchical polytomous regression models with applications to health services research. Stat Med. 1997; 16: 2311-2325.
16. Low RB, Ito S, Gregory R, et al. Using the GLIMMIX procedure to model hospital quality measured by CMS: comparing the city-owned hospitals, other safety net hospitals, and hospitals for the well insured. Paper presented at: SAS Global Forum 2010; April 11-15, 2010; Seattle, Wash. Paper 164-2010.
17. Snijders TAB, Bosker RJ,. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage Publications; 1999.
18. Joudi FN, Allareddy V, Kane CJ, Konety BR,. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol. 2007; 177: 1709-1714.
19. Gardner TA, Bissonette EA, Petroni GR, McClain R, Sokoloff MH, Theodorescu D,. Surgical and postoperative factors affecting length of hospital stay after radical prostatectomy. Cancer. 2000; 89: 424-430.
20. Stimson CJ, Chang SS, Barocas DA, et al. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol. 2010; 184: 1296-1300.
21. Gore JL, Lai J, Gilbert SM,. Readmissions in the postoperative period following urinary diversion. World J Urol. 2011; 29: 79-84.
22. van Walraven C, Dhalla IA, Bell C, et al. Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. CMAJ. 2010; 182: 551-557.
23. Forrest JB, Clemens JQ, Finamore P, et al. AUA best practice statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol. 2009; 181: 1170-1177.
24. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Eighth Edition). Chest. 2008; 133 (6 suppl): 381S-453S.
25. Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA Jr,. Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol. 2002; 167: 2012-2016.
26. Koya MP, Manoharan M, Kim SS, Soloway MS,. Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted? BJU Int. 2005; 96: 1019-1021.
27. Schoenberg MP, Gonzalgo ML,. Management of invasive and metastatic bladder cancer. In:, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. Philadelphia, PA: Saunders; 2006: 2468-2478.
28. Vaishampayan UN, Do H, Hussain M, Schwartz K,. Racial disparity in incidence patterns and outcome of kidney cancer. Urology. 2003; 62: 1012-1017.
29. Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD,. Provider treatment intensity and outcomes for patients with early stage bladder cancer. J Natl Cancer Inst. 2009; 101: 571-580.
30. New York State Department of Health. Adult Cardiac Surgery in New York State, 2006-2008. Albany, NY: New York State Department of Health; 2010.
31. Cuschieri J, Florence M, Flum DR, et al. Negative appendectomy and imaging accuracy in the Washington State Surgical Care and Outcomes Assessment Program. Ann Surg. 2008; 248: 557-563.
32. Flum DR, Fisher N, Thompson J, Marcus-Smith M, Florence M, Pellegrini CA,. Washington State's approach to variability in surgical processes/outcomes: Surgical Clinical Outcomes Assessment Program (SCOAP). Surgery. 2005; 138: 821-828.